
Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Base Year
Historical Year
Forecast Year
Hepatitis C is a viral infection caused by the Hepatitis C virus (HCV). It can lead to inflammation of the liver and can cause both acute and chronic illness. The initial infection with hepatitis C has few to no symptoms and is referred to as a silent killer. Direct-acting antivirals (DAAs) are the common medications prescribed for this viral infection, with the treatment plan often involving a combination of two or more DAAs. In North America, there is a growing investment in research initiatives by pharmaceutical companies and research institutions to develop new therapies and improve existing ones, which directly impacts the global hepatitis C market dynamics. Further, the continuous innovations in treatments and the advancements in diagnostic technologies are driving the North America hepatitis C market growth.
Hepatitis C is a serious health challenge in North America. In the United States, it ranks as the leading cause of liver failure and a major cause of liver transplants. Around 2.7 to 3.9 million individuals are estimated to be affected by chronic hepatitis C in the United States with nearly 17,000 new cases occurring every year in the region. The rising burden of this viral disease fuels the need for effective antiviral therapies and is a significant growth driver of the market. Moreover, the growing aging population more prone to contracting viral infections is likely to augment the North America hepatitis C market demand in the forecast period.
According to the Centers for Disease Control and Prevention (CDC) Report released in 2023, only 1 in 3 adults diagnosed with hepatitis C in the United States has been cured. To address this alarming trend, a National HCV Elimination Plan was proposed by the White House in their budget for 2023-2034. The 2024 budget allocated USD 12.3 billion to eliminate hepatitis C by next 10 years. By improving access to medical care and screening, the national plan is projected to save over 90,000 lives and almost USD 60 billion in healthcare costs by 2050. Such government initiatives focused on lowering the cost of treatment and expanding testing facilities are poised to boost the market share.
North America Hepatitis C Market Size
North America Hepatitis C Market Analysis
North America Hepatitis C Companies
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
The North America hepatitis C market is expected to be driven by the rising demand for the global market, which is anticipated to grow at a CAGR of 13.6% during the forecast period of 2025-2034 and is likely to reach a market value of USD 199.63 billion by 2034.
The rising healthcare expenditure and increasing innovations in treatment therapies are fuelling the demand for the market.
One of the significant trends in the market is the increased government investment in eliminating hepatitis C. The National HCV Elimination Plan proposed by the White House in their budget for 2023-2034 is projected to spend USD 12.3 billion to eliminate hepatitis C over the next 10 years.
Based on the type, the market is segmented into acute and chronic.
Treatments available in the market include immune modulator drugs, antiviral drugs, vaccines, and surgery, among others.
By route of administration, the market is divided into oral and parenteral, among others.
The market breakup by diagnosis includes liver biopsy, blood tests, and imaging tests, among others.
Distribution channels of the market are hospital pharmacies, retail pharmacies, and online pharmacies.
The market segmentation by countries includes the United States and Canada.
The key players in the market are Gilead Sciences, Inc., AbbVie Inc., Merck & Co., Inc., Bristol Myers Squibb, Johnson & Johnson, Roche Holding AG, Pfizer Inc., Novartis AG, Vertex Pharmaceuticals, and Boehringer Ingelheim.
Datasheet
One User
USD 2,699
USD 2,429
tax inclusive*
Single User License
One User
USD 4,299
USD 3,869
tax inclusive*
Five User License
Five User
USD 5,799
USD 4,949
tax inclusive*
Corporate License
Unlimited Users
USD 6,999
USD 5,949
tax inclusive*
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Small Business Bundle
Growth Bundle
Enterprise Bundle
*Please note that the prices mentioned below are starting prices for each bundle type. Kindly contact our team for further details.*
Flash Bundle
Number of Reports: 3
20%
tax inclusive*
Small Business Bundle
Number of Reports: 5
25%
tax inclusive*
Growth Bundle
Number of Reports: 8
30%
tax inclusive*
Enterprise Bundle
Number of Reports: 10
35%
tax inclusive*
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
United States
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61-448-061-727
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City, 1226.
+63-287-899-028, +63-967-048-3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84-865-399-124